Sep 12, 2025 18:46
CURX - Curanex Pharmaceuticals Inc Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 0.68 -0.01 (-1.21%) | --- | --- | 0.0 (0.0%) | 0.0 (0.13%) | 0.01 (1.8%) | 0.0 (0.0%) | 0.0 (0.0%) |
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 100.0
- VWAP:
- 0.67
- RVol:
- 0.0443
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price increase 1m | 0.69 +0.01 (+1.18%) | Oct 15 09:55 |
| 10m | Price increase 10m | 0.69 +0.03 (+5.22%) | Oct 15 09:32 |
Related News
Aug 27, 2025 21:00